IBC’s Cell Therapy Bioprocessing and Commercialization Conference

Print Friendly

September 30-October 2, 2015
Alexandria, VA

IBC’s Cell Therapy Bioprocessing and Commercialization Conference is designed to help companies deliver on the promise of this emerging market to achieve commercially viable and efficacious patient outcomes. This year’s meeting is designed for process scientists, engineers, quality and regulatory professionals, and industry executives seeking relevant and comprehensive solutions to industry challenges.

BioLife Solutions is sponsoring the Biopreservation, Supply Chain Management and Distribution session on Thursday, October 1st, in which Aby J. Mathew, Ph.D., Senior Vice President and Chief Technology Officer, will present Biopreservation and Biologistics-From Collection through Manufacture to Cold Chain Patient Delivery. BioLife is also pleased to co-sponsor this year’s Opening Networking Reception, September 30th.

Go to event site.

ISHRS 23rd Annual Scientific Meeting

Print Friendly

ISHRS Meeting logo
Chicago, Illinois
September 9-13, 2015

The International Society for Hair Restoration Surgeons (ISHRS) Annual Scientific Meeting is the premier meeting in the field of Hair Restoration Surgery. The meeting includes lectures, debates, panel discussions, video surgery in high definition, workshops, lunch symposia, scientific poster presentations, live patient viewing, and vendor exhibits. Attendees include experienced hair restoration surgeons, as well as physicians new to the field of Hair Restoration Surgery. The delegate list also includes surgical assistants and technicians.

BioLife Solutions representatives with be available in Booth #7 to discuss the benefits of HypoThermosol® as an ex vivo graft holding solution.

Go to event site.

 

2015 International Cord Blood Symposium

Print Friendly

June 11-13, 2015
San Francisco, CA

The scientific program for the 13th International Cord Blood Symposium (ICBS) brings all of the umbilical cord blood related fields of hematopoietic stem cell transplantation, banking, and potential in regenerative medicine. World renowned experts in the cord blood field will deliver presentations during plenary sessions and workshops. The program also offers many networking opportunities.

BioLife’s Senior Vice President & Chief Technology Officer, Aby J. Mathew, Ph.D., serves on the Planning Committee for the Scientific Program, and will serve as panel moderator for Using Industry Tools and Embedded Technologies during the Cord Blood Banking and Expansion Technologies session on Thursday, June 11, 4:05 pm-5:30 pm.

BioLife Solutions representatives welcome the opportunity to connect with conference delegates in Booth 207.

Go to event site.

ISCT 2015 Annual Meeting

Print Friendly

ISCT 2015: Coming of Age
Driving Clinical Advances in Cell TherapyISCT2015Logo_250pixels

Caesars Palace, Las Vegas
May 27-30, 2015

ISCT is a global association dedicated to driving the translation of scientific research aimed at delivering innovative cellular therapies to patients. It is the only group focused on the pre-clinical and translational aspects of developing cell therapy products. Over 1,200 international delegates are expected to attend this year’s meeting, including MD and PhD clinicians and scientists, laboratory professionals involved in cell-processing programs/facilities, and industry personnel from cell therapy and enabling technology companies.

BioLife Solutions and biologistex™  representatives look forward to connecting with delegates in Booth 205 throughout the meeting, and also at the following BioLife sponsored events:

Opening Welcome Reception – May 27, 7:30 – 9:30 pm, Exhibition Hall

Corporate Tutorial – May 29, 12:45 – 1:45 pm – Aby J. Mathew PhD, BioLife Senior Vice President & Chief Technology Officer, presents Biopreservation, Biologistics, Patient Delivery, and Cell Thawing Media – Oh My!

BioLife representatives will also participate in the following sessions:

Strategies for Commercialization Track 5– May 29, 11:15 – 12:30 pm – Biologistics: Optimizing Costs of Cold Supply Chain with panelist, Kevin O’Donnell, VP of Cold Chain Standards Practices & Compliance Cell Therapy, BioLife/biologistex™

Plenary Session Four -May 29, 2:00-3:30 pm – Game Changers: Policy and Practice Changes Enabling the Commercialization of Cell and Tissue Products, Chair: Aby J. Mathew, PhD

Go to event site.

13th Cold Chain GDP & Temperature Management Logistics Summit – Canada

Print Friendly

Hilton Montreal Bonaventure, Montreal, Quebec
February 23 – 26, 2015

The 13th Annual Cold Chain GDP & Temperature Management Logistics Summit – Canada, is the largest event of its kind for life sciences in the Canadian market. The program has been expanded to cover clinical supply, biologics, supply chain integrity and small pharma/biotech supply chains, to better address the Canadian and Montreal markets. Attendees will have access to supply chain stakeholders in world-class companies operating in pharmaceuticals, health technologies, biotechnology and contract manufacturing/research.

Kevin O’Donnell, BioLife’s Vice President, Cold Chain Standards, Practices & Compliance, will present Web-Connected Biologistics: Cold Chain Lessons Learned from the Pharmaceutical Industry and how SMART Shippers have Come of Age; Wednesday, February 25, 2015 | Main Conference Day 1.

Go to Event Site

 

Phacilitate’s Cell & Gene Therapy Forum 2015

Print Friendly

Washington, DC
January 26-28, 2015
BioLife Booth #68

Phacilitate’s Cell & Gene Therapy Forum is the world’s biggest and fastest growing cell & gene therapy business meeting. It is the leading event driving product commercialization, and draws the most senior audience of any cell & gene event, with 76% Director level and above.

BioLife’s Aby J. Mathew, Ph.D., has been selected to chair Focus Session 2, Day 1, and will present Logistics 1: Placing logistics at the heart of the cell & gene therapy business model. His presentation will focus on maximizing quality control and minimizing ‘Cost of Logistics’ for cell and gene therapy products.

Go to Event Site

ECI Scale-Up and Manufacturing of Cell-Based Therapies IV

Print Friendly

San Diego, CA
January 18-22, 2015

The fourth annual conference on Scale-Up and Manufacturing of Cell-Based Therapies is scheduled for January 18-22, 2015 and will take place at the Hyatt Regency in San Diego.

This conference will focus on process development, scale-up, and manufacturing of cell-based therapies and will bring academicians, clinicians, industry leaders, and regulators from all over the world together to discuss the most critical scientific and engineering challenges in this field. The conference aim is to continue to play a central role in defining and refining the engineering sciences of cell-based therapies.

BioLife’s Senior Vice President and Chief Technology Officer, Aby J. Mathew, PhD, will present Biopreservation and Biologistics Considerations for GMP Manufacturing during Session 5: Industrial Highlights: Cell therapy manufacturing and implementation solutions.

Go to Event Site

TERMIS-AM

Print Friendly

December 13-16, 2014
Renaissance Hotel
Washington, DC

The TERMIS-AM Meeting is the key annual meeting held in the Americas each year, and brings together over 800 researchers, scientists, trainees, and students from both academia and industry to discuss critical developments in the field. The meeting is led by keynote speakers each day, and consists of parallel technical sessions as well as poster presentations. A strong role in the meeting planning and execution will be played by the TERMIS-AM Student and Young Investigator Section (SYIS).

BioLife Solutions is sponsoring this year’s Commercialization & Regulation TWIG Business Plan Competition.

Go to Event Site

IBC’s Inaugural Commercialization of Cell, Gene & Immunotherapies Conference

Print Friendly

Accelerating the Translation of Commercially Viable, Cell, Gene, and Immunotherapies Through Bioprocess Tools and Technologies

December 11-12, 2014
Andaz San Diego
San Diego, California

This new event will cover the exciting progress to accelerate the translation of commercially viable cell, gene and immunotherapies through the implementation of novel bioprocessing tools and technologies.

Aby J. Mathew, Ph.D., Senior Vice President & Chief Technology Officer, BioLife Solutions, will present Biologistics Considerations for Commercial GMP Manufacturing, Friday, December 12th at 2:00 PM.

Go to Event Site

AABB Annual Meeting 2014

Print Friendly

AABB2014

Booth 1533

As the premier event for the transfusion medicine and cellular therapies industry, attendees will learn the latest in transfusion medicine and cellular therapies, advance their career, explore state-of-the-art products and services and network with colleagues. The event boasts approximately 6,000 attendees, over 120 educational sessions, approximately 700 scientific and administrative abstracts, and an exhibit hall filled with nearly 200 companies.

BioLife’s Senior Vice President and Chief Technology Officer, Aby J. Mathew, PhD, will serve as a Table Moderator during the meeting session entitled “The So-Cell Network”: Round Table Discussions for Cellular Therapy Professionals.
Topic: “Cell Concentration During Cryopreservation: Does It Matter?”
Saturday, October 25, 2014
4:00 – 5:30 pm

BioLife Solutions will, once again, sponsor the Cellular Therapy Sizzling Topics Luncheon:
Sunday, October 26
Noon – 2:00 pm
(Included in registration fee, ticket required for entry)

Go to Event Site